<Record>
<Term>Recombinant Vaccinia-TRP1</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Vaccinia Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Vaccinia Vaccine/Recombinant Vaccinia-TRP1</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Vaccinia Vaccine</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Recombinant Vaccinia-TRP1</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Recombinant Vaccinia-TRP1</Synonym>
<Synonym>Tyrosinase-Related Protein-1-Vaccinia</Synonym>
<Synonym>rV-TRP1</Synonym>
<Description>A recombinant vaccinia virus encoding the melanocyte differentiation antigen tyrosinase-related protein-1 (TRP-1) with potential use in cancer immunotherapy. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
